-
Sector Analysis
Syrups and Spreads Market Opportunities, Trends, Growth Analysis and Forecast to 2027
Syrups and Spreads Market Report Overview The syrups and spreads market size was estimated at $42.3 billion in 2022 and is likely to grow at a CAGR of more than 2% from 2022 to 2027. The growing demand for syrups and spreads made with organic and natural ingredients owing to rising health & wellness trends will drive the market growth. Syrups and Spreads Market Outlook 2022-2027 ($ Billion) Buy the Full Report for Syrups and Spreads Market Forecasts Download a...
-
Product Insights
Likelihood of Approval Analysis for Inherited Metabolic Disorders
Overview How likely is it that the drugs in Inherited Metabolic Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Inherited Metabolic Disorders Overview Genetic defects causing metabolic problems are referred...
-
Product Insights
Likelihood of Approval Analysis for Amino Acid Metabolism Disorders
Overview How likely is it that the drugs in Amino Acid Metabolism Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Amino Acid Metabolism Disorders Overview Amino acids are building blocks...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NVCoV-2 in Respiratory Syncytial Virus (RSV) Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NVCoV-2 in Respiratory Syncytial Virus (RSV) Infections report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NVCoV-2 in Respiratory Syncytial Virus (RSV) Infections Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NVCoV-2 in Middle East Respiratory Syndrome (MERS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NVCoV-2 in Middle East Respiratory Syndrome (MERS) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NVCoV-2 in Middle East Respiratory Syndrome (MERS) Drug...
-
Thematic Analysis
Global Tech, Media, and Telecom (TMT) M&A Deals 2023 – Top Themes and Predictions – Thematic Intelligence
Global Tech, Media, and Telecom (TMT) M&A Deals 2023 Theme and Predictions Report Overview Total M&A deal value in the technology, media, and telecom (TMT) sector declined 46% in 2023, compared to the previous year. Software and services accounted for over 48% share of the total M&A deal value in 2023. The ‘Global Tech, Media, And Telecom (TMT) M&A Deals 2023 Theme and Predictions Report’ analyzes the top disruptive themes that drove M&A activity in the technology, media, and telecom (TMT)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EN-001 in Exocrine Pancreatic Insufficiency
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EN-001 in Exocrine Pancreatic Insufficiency report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.EN-001 in Exocrine Pancreatic InsufficiencyDrug Details:EN-001 is under development for the treatment...
-
Company Profile
Britvic Plc – Company Profile
Britvic Plc (Britvic) is a manufacturer and marketer of soft drinks. The company's product portfolio includes energy drinks, packaged water, carbonates, syrups, juice, squash, and sparkling soda. Britvic markets its products under Robinsons, Gatorade, Drench, Ballygowan, Tango, J2O, MiWadi, Pressade, Fruit Shoot, Cidona, Teisseire, Fruite, Robinsons Fruit Cordial, Club, and TK brand names. Through its licensing agreements with PepsiCo, Britvic produces and markets soft drink brands, such as Pepsi MAX, 7UP, SoBe, and Mountain Dew. The company has business operations...
Add to Basket -
Company Profile
Olvi plc – Company Profile
Olvi plc (Olvi) manufactures, distributes, and markets alcoholic and non-alcoholic beverages. The company’s product portfolio includes beers, ciders, whiskey, wine, gin, long drinks, energy drinks, soft drinks, juices, sports beverages, syrups, kvass, mineral water and other alcoholic and non alcoholic beverages. Olvi sells its products under the brands of OLVI, A. Le Coq, Muteman, Daring Daughter, A. Le Coq Fassbrause, Sandels, Motor Oil, Sherwood, Olvi Vichy, FIZZ, KevytOlo, Kane’s Soda Pop and TEHO, among others. It also provides service of...
Add to Basket